Who
Faith L. Charles
Director
Company insider
Files Form 4 as: Director, CNS Pharmaceuticals; Director, Abeona Therapeutics; Director, CDT Equity; Director, Avenue Therapeutics.
In numbers
- Trades disclosed
- 28
- Buys
- 2
- Sells
- 2
- Bought
- $93K
- Sold
- $104K
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 25 May 2021
- Last trade
- 18 May 2026
- Last filed
- 20 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 May 2026filed 20 May 2026 | CNSP CNS PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $34K7,100 at $4.79 | filing |
| 18 May 2026filed 20 May 2026 | CNSP CNS PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $34K7,100 at $4.79 | filing |
| 26 Jan 2026filed 27 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,313 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,313 at $0.00 | filing |
| 17 Nov 2025filed 19 Nov 2025 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,517 at $0.00 | filing |
| 9 Jul 2025filed 10 Jul 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $63K10,738 at $5.86 | filing |
| 16 Apr 2025filed 17 Apr 2025 | CDT CDT EquityBiotechnology | SEC FORM 4 Code A | $100K115,194 at $0.87 | filing |
| 30 Mar 2025filed 1 Apr 2025 | CDT CDT EquityBiotechnology | SEC FORM 4 Code A | $41K46,629 at $0.89 | filing |
| 31 Jan 2025filed 3 Feb 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —36,101 at $0.00 | filing |
| 18 Dec 2024filed 20 Dec 2024 | CDT CDT Equityoption or derivative · Biotechnology | SEC FORM 4 Code A | $29K420,000 at $0.07 | filing |
| 18 Nov 2024filed 20 Nov 2024 | CDT CDT EquityBiotechnology | SEC FORM 4 Code A | —75,000 | filing |
| 18 Nov 2024filed 20 Nov 2024 | CDT CDT EquityBiotechnology | SEC FORM 4 Code A | $24K266,594 at $0.09 | filing |
| 23 Sep 2024filed 25 Sep 2024 | Avenue Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 26 Aug 2024filed 27 Aug 2024 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —11,797 at $0.00 | filing |
| 8 Jul 2024filed 9 Jul 2024 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —23,611 at $0.00 | filing |
| 26 Apr 2024filed 29 Apr 2024 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Bought | $25K7,550 at $3.28 | filing |
| 8 Apr 2024filed 10 Apr 2024 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,500 | filing |
| 8 Apr 2024filed 10 Apr 2024 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,500 | filing |
| 1 Dec 2023filed 5 Dec 2023 | CDT CDT Equityoption or derivative · Biotechnology | SEC FORM 4 Code A | $358K65,000 at $5.51 | filing |
| 27 Sep 2023filed 29 Sep 2023 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $41K8,330 at $4.91 | filing |
News
No headline names them, or the companies they trade most, lately.